Back to search results
NCT06139666

The Effect of Liposomal Bupivacaine Nerve Block (Exparel) in Rotator Cuff Surgery

UNKNOWN
PHASE4Ages 18+InterventionalTreatment
The Cooper Health System
~160 participants
Updated 2024-08-20 on ClinicalTrials.gov
What's tested:Exparel Injectable SolutionBupivacaine Injectable Solution

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Use of pain medications
Measured over 2 week postoperative visit

Conditions

Rotator Cuff Tears
Postoperative Pain
Opioid Use

Explore related trials

Post-Operative PainRupture of rotator cuff of shoulder

NCT06139666

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Cooper University Hospital

    Camden, New Jerseyno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Catherine J Fedorka, MD · PRINCIPAL_INVESTIGATOR · The Cooper Health System

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients above 18 years of age
Undergoing rotator cuff surgery or shoulder arthroscopy using an interscalene block

Exclusion

Patients with preexisting chronic obstructive pulmonary disease (COPD) or respiratory issues precluding the use of an interscalene block
Pregnant women, women nursing infants
Patients with preexisting liver disease
Patients unwilling to have interscalene block performed
Patients allergic to bupivacaine, liposomal bupivacaine, or any ingredients contained within the two drugs listed

What this trial measures

  • Use of pain medications2 week postoperative visit

    Patients will be asked to bring their bottle of pain medication prescribed after surgery to their first office visit so a narcotic pill count can be performed. Patients will record their pain pill consumption every day for 2 weeks in a study journal. The journal containing the pill count will be collected at the 2 week visit in the office. Opioid consumption will be quantified as milligram of opioid equivalents (MME).